Breast Cancer, Ovarian Cancer, Gynecologic Cancers,
Location: Stanford CA
Sponsor: Stanford University
Sex: Female
Age: 18+
Code: NCT01034033
Recruiting
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
for
Metastatic Breast Cancer
Location: Boston MA
Sponsor: Rogers Sciences Inc.
Sex: All
Age: 18+
Code: NCT02939274
Phase2, Recruiting
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
for
Breast Cancer, Metastatic Breast Cancer
Location: Chapel Hill NC, Birmingham AL
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06855654
Recruiting
BREAST Choice Decision Tool R21 - AIM2
for
Breast Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06817226
Recruiting
Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12
for
Breast Cancer
Location: Las Vegas NV
Sponsor: University of Nevada, Las Vegas
Sex: All
Age: 18 - 70
Code: NCT01679223
Recruiting
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
for
Breast Cancer, Relapse, Resistant Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06347068
Phase1, Recruiting
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
for
Breast Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: Female
Age: 18+
Code: NCT06444269
Phase2, Recruiting
A Multicenter Breast Cancer Biospecimen Registry
for
Breast Cancer
Location: Dallas TX, Redding CA
Sponsor: Luminist, Inc.
Sex: Female
Age: 40+
Code: NCT02712645
Recruiting
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy
for
Breast Cancer, High Risk of Breast Cancer
Location: Dallas TX
Sponsor: Deborah Farr, MD
Sex: Female
Age: 18 - 70+
Code: NCT05245812
Recruiting
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
for
Hormone Receptor-positive Breast Cancer,
Location: Boston MA, Fairfax VA, Tampa FL, Detroit MI,
Sponsor: Ellipses Pharma
Sex: Female
Age: 18+
Code: NCT05573126
Phase1, Phase2, Recruiting
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17